Cargando…

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been widely used for the treatment of arthritic conditions. Drugs in this heterogeneous class alleviate pain and inflammation by inhibiting cyclooxygenase-2 (COX-2). Cyclooxygenase-1 (COX-1) inhibition has traditionally been associated with increase...

Descripción completa

Detalles Bibliográficos
Autor principal:	Walker, Chris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304524/ https://www.ncbi.nlm.nih.gov/pubmed/30631366 http://dx.doi.org/10.1155/2018/1302835

Ejemplares similares

Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”
por: Walker, Chris
Publicado: (2019)

Seizure following the Use of the COX-2 Inhibitor Etoricoxib
por: Arnao, Valentina, et al.
Publicado: (2017)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison
por: Stam, WB, et al.
Publicado: (2012)

Multifocal Fixed Drug Eruption with COX-2 Inhibitor-Celecoxib
por: Chugh, Shikha, et al.
Publicado: (2013)

Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same
por: Pradal, Julie, et al.
Publicado: (2019)

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)
por: Dhondt, Laura, et al.
Publicado: (2017)

Cost-Effectiveness Evaluation of Etoricoxib versus Celecoxib and Nonselective NSAIDs in the Treatment of Ankylosing Spondylitis in Norway
por: Jansen, Jeroen P., et al.
Publicado: (2011)

A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo
por: Cannon, Christopher P, et al.
Publicado: (2008)

Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients*
por: Walker, Chris, et al.
Publicado: (2016)

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice
por: Klenke, Frank Michael, et al.
Publicado: (2006)

Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model
por: Jin, Zhixing, et al.
Publicado: (2020)

Effects of diclofenac and celecoxib on osteoclastogenesis during alveolar bone healing, in vivo
por: Ghalayani, Parichehr, et al.
Publicado: (2014)

Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis
por: Huang, Hetao, et al.
Publicado: (2020)

Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis
por: Nițescu, Diana Ana-Maria, et al.
Publicado: (2022)

Celecoxib and Etoricoxib may reduce risk of ischemic stroke in patients with rheumatoid arthritis: A nationwide retrospective cohort study
por: Chen, Acer I-Hung, et al.
Publicado: (2022)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Effects of the Highly COX-2-Selective Analgesic NSAID Etoricoxib on Human Periodontal Ligament Fibroblasts during Compressive Orthodontic Mechanical Strain
por: Kirschneck, Christian, et al.
Publicado: (2019)

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations
por: Scolnik, Marina, et al.
Publicado: (2011)

Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis
por: Shirata, Toshinori, et al.
Publicado: (2023)

Ionisable substances chromatography: A new approach for the determination of Ketoprofen, Etoricoxib, and Diclofenac sodium in pharmaceuticals using ion – pair HPLC
por: Andraws, Georgeos, et al.
Publicado: (2020)

Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms
por: Sakane, K.K., et al.
Publicado: (2013)

RT-qPCR study of COX-1 and -2 genes in oral surgical model comparing single-dose preemptive ibuprofen and etoricoxib: A randomized clinical trialy
por: Medeiros-Albuquerque, Assis-Filipe, et al.
Publicado: (2020)

Etoricoxib for arthritis and pain management
por: Brooks, Peter, et al.
Publicado: (2006)

The cardiovascular risks of etoricoxib (Arcoxia)
por: Sasich, Larry D., et al.
Publicado: (2008)

Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro
por: Scheinichen, Dirk, et al.
Publicado: (2004)

Comparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial
por: Boonriong, Tanarat, et al.
Publicado: (2010)

Post exposition to etoricoxib in patients with negative oral drug provocation tests
por: Sterza, Thais, et al.
Publicado: (2015)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis
por: Sun, Ling
Publicado: (2021)

Celecoxib vs diclofenac sodium in patients with knee osteoarthritis: A protocol for systematic review and meta analysis
por: Huang, Hetao, et al.
Publicado: (2020)

Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity
por: Fernandes, L, et al.
Publicado: (2003)

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia
por: Farooqui, M, et al.
Publicado: (2007)

Etoricoxib-induced pretibial erythema and edema
por: Kumar, Pramod
Publicado: (2015)

Exantema fijo medicamentoso por etoricoxib
por: Cantero Macedo, Ana Margarita, et al.
Publicado: (2019)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013)

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial
por: Bickham, Kara, et al.
Publicado: (2016)

Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial§
por: Kellner, Herbert L., et al.
Publicado: (2013)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

Anaphylaxis to selective COX-2 inhibitors: an unexpected culprit
por: Dias de Castro, Eunice, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v0pb5cirfnmff9vrfdo9m7ehrg